Le Lézard
Classified in: Health
Subjects: VET, ATY, DEI

Minnesota Mesothelioma Victims Center Has Just Endorsed Attorney Erik Karst of Karst von Oiste to Ensure the Best Compensation Results for a Person with Mesothelioma or Asbestos Exposure Lung Cancer in Minnesota-Don't Settle for Less


MINNEAPOLIS, Aug. 23, 2023 /PRNewswire/ -- The Minnesota Mesothelioma Victims Center has just endorsed attorney Erik Karst of the law firm of Karst von Oiste to be the go to compensation-legal expert for a person with recently diagnosed mesothelioma or asbestos exposure lung cancer anywhere in Minnesota. Attorney Erik Karst is one of the nation's leading mesothelioma-asbestos exposure lung cancer attorneys and he has been assisting people like this in Minnesota for over a decade. For direct access to attorney Erik Karst please call 866-714-6466 anytime. www.karstvonoiste.com/

According to the Minnesota Mesothelioma Victims Center, "The reason we have just endorsed attorney Erik Karst of Karst von Oiste is to make certain the best financial compensation results happen for a person with just diagnosed mesothelioma or asbestos exposure lung cancer anywhere in Minnesota. Attorney Erik Karst has been assisting people with mesothelioma as well as asbestos exposure lung cancer all over Minnesota for over a decade. For direct access to attorney Erik Karst please call 866-714-6466-anytime.

"The Mesothelioma Victims Center has been assisting people with mesothelioma nationwide for nearly two decades. The reason we are now beginning to endorse specialist mesothelioma and or asbestos exposure lung cancer attorneys on a state specific basis is because-this is what people with these cancers want. We want a person in Minnesota with mesothelioma-or asbestos exposure lung cancer to talk directly with attorney Erik Karst-at 866-714-6466 because he has so much experience assisting people like this-and he gets top compensation results for his clients." www.karstvonoiste.com/

Suggestions from the Mesothelioma Victims Center for people with mesothelioma or asbestos exposure lung cancer in Minnesota or nationwide on how to increase potential financial compensation:

Special note from the Mesothelioma Victims Center- "We are thrilled to endorse attorney Erik Karst of the law firm of Karst von Oiste for a person with mesothelioma or asbestos exposure lung cancer in Minnesota. We will soon be endorsing other incredibly qualified attorneys who specialize in mesothelioma-asbestos exposure lung cancer compensation in a few other states-to ensure people in these states have on the spot access to top local legal experts. In the meantime, if a person with mesothelioma or asbestos exposure lung cancer anywhere in the nation-or their family members would like some suggestions as to what lawyer-law firm to call-please call us anytime at 866-714-6466. It would be an honor to help." https://MesotheliomaVictimsCenter.Com

Media Contact:
Michael Thomas
866-714-6466
[email protected] 

SOURCE Minnesota Mesothelioma Victims Center


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: